Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: A new concept of adjuvant glioma therapy?

Lasers in Surgery and Medicine

Volumn 33, Issue 2, 2003, Pages 75-80

  Sabel, Michael ^a   Rommel, Frank ^a   Kondakci, Mustafa ^a   Gorol, Marion ^a   Willers, Reinhard ^a   Bilzer, Thomas ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Chemotherapy; HPLC; Immunohistochemistry; LITT

Indexed keywords

COMPLEMENT COMPONENT C3; EVANS BLUE; FIBRINOGEN; IMMUNOGLOBULIN M; PACLITAXEL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN TUMOR; CANCER CHEMOTHERAPY; CONTROLLED STUDY; DRUG BLOOD LEVEL; GLIOMA; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYPERTHERMIC THERAPY; IMMUNOHISTOCHEMISTRY; LASER INDUCED THERMOTHERAPY; MEMBRANE PERMEABILITY; NEODYMIUM LASER; NEUROANATOMY; NONHUMAN; PERFUSION; PRIORITY JOURNAL; RAT;

ADMINISTRATION, TOPICAL; ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BLOOD-BRAIN BARRIER; BRAIN NEOPLASMS; CHEMOTHERAPY, ADJUVANT; GLIOMA; HYPERTHERMIA, INDUCED; LASER SURGERY; NEUROSURGICAL PROCEDURES; PACLITAXEL; PERMEABILITY; RATS; RATS, INBRED F344;

EID: 0141595179     PISSN: 01968092     EISSN: None     Source Type: Journal    
DOI: 10.1002/lsm.10181     Document Type: Article

References (32)

1. Kroll RA, Neuwelt EA. Outwitting the blood-brain barrier for therapeutic purposes: Osmotic opening and other means. Neurosurgery 1998;42:1083-1099; discussion 1099-1100.
2. Neuwelt EA, Frenkel EP, Diehl J, et al. Reversible osmotic blood-brain barrier disruption in humans. Implications for the chemotherapy of malignant brain tumors. Neurosurgery 1980;7:44-52.
3. Millay RH, Klein ML, Shults WT, et al. Maculopathy associated with combination chemotherapy and osmotic opening of the blood-brain barrier. Am J Ophthalmol 1986;102:626-632.
4. Neuwelt EA, Glasberg M, Frenkel E, et al. Neurotoxicity of chemotherapeutic agents after blood-brain barrier modification. Neuropathological studies. Ann Neurol 1983;14:316-324.
5. Tomiwa K, Hazama F, Mikawa H. Neurotoxicity of vincristine after the osmotic opening of the blood-brain barrier. Neuropathol Appl Neurobiol 1983;9:345-354.
6. Menovsky T, Beek JF, van Gemert MJ, et al. Interstitial laser thermotherapy in neurosurgery. A review. Acta Neurochir (Wien) 1996;138:1019-1026.
7. Frank F, Hessel S. Technische Voraussetzungen für die interstitielle thermotherapie mit dem Nd.YAG Laser. Laser-medizin 1990;0:36-40.
8. Kahn T, Bettag M, Harth T, et al. [Laser-induced interstitial induced hyperthermia of cerebral tumors with nuclear magnetic resonance tomography control]. Radiologe 1996;36: 713-721.
9. Kahn T, Harth T, Bettag M, et al. Preliminary experience with the application of gadolinium-DTPA before MR imaging-guided laser-induced interstitial thermotherapy of brain tumors. J Magn Reson Imaging 1997;7:226-229.
10. Kahn T, Schwabe B, Bettag M, et al. Mapping of the cortical motor hand area with functional MR imaging and MR imaging-guided laser-induced interstitial thermotherapy of brain tumors. Work in progress. Radiology 1996;200:149-157.
11. Eggert HR, Kiessling M, Kleihues P. Time course and spatial distribution of neodymium. Yttrium-aluminum-garnet (Nd.YAG) laser-induced lesions in the rat brain. Neurosurgery 1985;16:443-448.
12. Kiessling M, Herchenhan E, Eggert HR. Cerebrovascular and metabolic effects on the rat brain of focal Nd.YAG laser irradiation. J Neurosurg 1990;73:909-917.
13. Schober R, Bettag M, Sabel M, et al. Fine structure of zonal changes in experimental Nd.YAG laser-induced interstitial hyperthermia. Lasers Surg Med 1993;1:234-241.
14. Wharen RE, Jr., Anderson RE, Scheithauer B, et al. The Nd.YAG laser in neurosurgery. Part 1. Laboratory investigations. Dose-related biological response of neural tissue. J Neurosurg 1984;60:531-539.
15. Glantz MJ, Choy H, Kearns CM, et al. Paclitaxel disposition in plasma and central nervous systems of humans and rats with brain tumors. J Natl Cancer Inst 1995;87:1077-1081.
16. Sakai T, Fujishima I, Sugiyama K, et al. Interstitial laser-thermia in neurosurgery. J Clin Laser Med Surg 1992;10: 37-40.
17. Ikeda N, Hayashida O, Kameda H, et al. Experimental study on thermal damage to dog normal brain. Int J Hyperthermia 1994;10:553-561.
18. Shivers RR, Wijsman JA. Blood-brain barrier permeability during hyperthermia. Prog Brain Res 1998;115:413-424.
19. Wijsman JA, Shivers RR. Heat stress affects blood-brain barrier permeability to horseradish peroxidase in mice. Acta Neuropathol (Berl) 1993;86:49-54.
20. 2+ mediate hyperosmolal opening of the blood-brain barrier. in vitro studies in isolated rat cerebral capillaries. J Neurohem 1989;52:1135-1142.
21. Trout JJ, Koenig H, Goldstone AD, et al. Blood-brain barrier breakdown by cold injury. Polyamine signals mediate acute stimulation of endocytosis, vesicular transport, and microvillus formation in rat cerebral capillaries. Lab Invest 1986; 55:622-631.
22. Harari PM, Fuller DJ, Gerner EW. Heat shock stimulates polyamine oxidation by two distinct mechanisms in mammalian cell cultures. Int J Radiat Oncol Biol Phys 1989;16:451-457.
23. Millan N, Murdock LL, Bleier R, et al. Effects of acute hyperthermia on polyribosomes, in vivo protein synthesis, and ornithine decarboxylase activity in the neonatal rat brain. J Neurochem 1979;32:311-317.
24. Alm P, Sharma HS, Hedlund S, et al. Nitric oxide in the pathophysiology of hyperthermic brain injury. Influence of a new anti-oxidant compound H-290/51. A pharmacological study using immunohistochemistry in the rat. Amino Acids 1998;14:95-103.
25. Longnecker SM, Donehower RC, Cates AE, et al. High-performance liquid chromatographic assay for taxol in human plasma and urine and pharmacokinetics in a phase I trial. Cancer Treat Rep 1987;71:53-59.
26. Cordes N, Plasswilm L. Cell line and schedule-dependent cytotoxicity of paclitaxel (taxol). Role of the solvent cremophor EL/ethanol. Anticancer Res 1998;18:1851-1857.
27. Terzis AJ, Thorsen F, Heese O, et al. Proliferation, migration, and invasion of human glioma cells exposed to paclitaxel (taxol) in vitro. Br J Cancer 1997;75:1744-1752.
28. Chang SM, Kuhn JG, Rizzo J, et al. Phase I study of paclitaxel in patients with recurrent malignant glioma. A North American brain tumor consortium report. J Clin Oncol 1998; 16:2188-2194.
29. Glantz MJ, Chamberlain MC, Chang SM, et al. The role of paclitaxel in the treatment of primary and metastatic brain tumors. Semin Radiat Oncol 1999;9:27-33.
30. Prados MD, Schold SC, Spence AM, et al. Phase II study of paclitaxel in patients with recurrent malignant glioma. J Clin Oncol 1996;14:2316-2321.
31. Tishler RB, Geard CR, Hall EJ, et al. Taxol sensitizes human astrocytoma cells to radiation. Cancer Res 1992;52:3495-3497.
32. Tishler RB, Schiff PB, Geard CR, et al. Taxol. A novel radiation sensitizer. Int J Radiat Oncol Biol Phys 1992;22: 613-617.